SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001012477-18-000012
Filing Date
2018-05-02
Accepted
2018-05-02 09:03:00
Documents
6
Period of Report
2018-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K avadel_8kx20180502.htm 8-K 28825
2 EXHIBIT 99.1 q12018earningsrelease.htm EX-99.1 748102
3 EXHIBIT 99.2 q12018earningscallslides.pdf EX-99.2 1598504
4 EXHIBIT 99.3 noctivalaunchnewsreleasev0.htm EX-99.3 24953
5 noctivalaunchnewsrele_image1.gif GRAPHIC 4093
6 q12017earningsrelease_image1.jpg GRAPHIC 7409
  Complete submission text file 0001012477-18-000012.txt   3019338
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 18797717
SIC: 2834 Pharmaceutical Preparations